It is differentially expressed in some tumor types – in hepatocellular carcinoma and melanoma, GPC3 is highly expressed [18]; however, its expression is reduced in ovarian and breast cancer [19, 20], a finding which suggests that GPC3 may be involved in tumor development [21]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.